FDA Inspection 1256101 — Allan J. Dinnerstein, M.D.
The FDA completed an inspection of Allan J. Dinnerstein, M.D. on November 4, 2024 in Boynton Beach, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 4, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Boynton Beach, FL (United States)
Additional Details
Clinical Investigator (CI)